This Is MS Multiple Sclerosis Community: Knowledge & Support

Just noticed that the Accelerated Cure Project has their biobank program on Clinicaltrials.gov now. I hope they are having an easy time recruiting, this is a really worthwhile effort I think.



Biobank For MS And Other Demyelinating Diseases

This study is currently recruiting patients.
Verified by Accelerated Cure Project for Multiple Sclerosis March 2007

Purpose
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.

Condition
Multiple Sclerosis
Transverse Myelitis
Neuromyelitis Optica
Acute Disseminated Encephalomyelitis
Optic Neuritis

Study start: May 2006

Inclusion Criteria:
* able to give informed consent
* willing to provide up to 110 ml of blood via venipuncture
* experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON

Exclusion Criteria:
* history of blood borne pathogens
* allogeneic bone marrow transplant
* clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).

Location and Contact Information
Sara Loud 781-487-0008 acp-study-director@acceleratedcure.org

United States, Arizona
Barrow Neurological Institute, Phoenix, Arizona, 85013, United States; Recruiting
Taira Kochar 602-406-6992 acp-study-barrow@acceleratedcure.org

United States, Georgia
Shepherd Center, Atlanta, Georgia, 30309, United States; Recruiting
Elizabeth Iski 404-350-3116 acp-study-shepherd@acceleratedcure.org
Benjamin Thrower, M.D., Principal Investigator

United States, Maryland
Johns Hopkins, Baltimore, Maryland, 21287, United States; Recruiting
Jana Goins 410-502-6160 acp-study-hopkins@acceleratedcure.org
Ben Greenberg, M.D., M.H.S., Principal Investigator

United States, Massachusetts
University of Massachusetts Medical School, Worcester, Massachusetts, 01605, United States; Recruiting
Janice Weaver 508-793-6562 acp-study-umass@acceleratedcure.org
Peter Riskind, M.D., Principal Investigator

United States, New York
Multiple Sclerosis Research Center of New York, New York, New York, 10019, United States; Recruiting
Emily Denicore Eisenberg 212-265-8070 acp-study-msrcny@acceleratedcure.org
Saud Sadiq, M.D., Principal Investigator

United States, Texas
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 76051, United States; Not yet recruiting
Gina Remington 214-645-0560 acp-study-utsw@acceleratedcure.org
Elliot Frohman, M.D., Principal Investigator

Study chairs or principal investigators
Benjamin Greenberg, M.D., M.H.S., Principal Investigator, Johns Hopkins


http://www.clinicaltrials.gov/ct/show/N ... 7?order=57